A multicenter, prospective, randomized trial of the efficacy and safety of Alflutop® in an alternating dosing regimen versus the standard one. Communication 2: Evaluation of the efficacy of the drug in different use regimens

A multicenter, prospective, randomized trial of the efficacy and safety of Alflutop® in an alternating dosing regimen versus the standard one. Communication 2: Evaluation of the efficacy of the drug in different use regimens

Osteoarthritis (OA) belongs to diseases with high comorbidity and most frequently concurrent with obesity, diabetes mellitus (DM), hypertension, and other cardiovascular diseases (coronary heart disease, atherosclerosis), gastrointestinal tract diseases, and chronic diseases of the lung and kidney....

Full description

Bibliographic Details
Main Authors: E. P. Sharapova, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova, S. G. Anikin, E. A. Strebkova, A. M. Lila, V. I. Mazurov, N. A. Shostak, E. I. Shmidt, E. P. Ilivanova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-03-01
Series:Современная ревматология
Subjects:
osteoarthritis
comorbidity
extended-release symptomatic drugs
alflutop
efficacy
safety
Online Access:https://mrj.ima-press.net/mrj/article/view/995

Internet

https://mrj.ima-press.net/mrj/article/view/995

Similar Items